Literature DB >> 1430030

Chiral separations of basic drugs and quantitation of bupivacaine enantiomers in serum by capillary electrophoresis with modified cyclodextrin buffers.

H Soini1, M L Riekkola, M V Novotny.   

Abstract

Modified cyclodextrin derivatives were evaluated as the buffer additives in capillary electrophoresis of several racemic pharmaceutical bases. Uncoated and polyacrylamide-modified silica capillaries were compared for their effectiveness in the enantiomeric resolution and migration reproducibility of model solutes. Using cationic detergents in the mixed-micellar mode, optimized separations of the racemic drug bupivacaine are demonstrated in a spiked serum sample at the therapeutic level. Precision, linearity and sensitivity of the method appear adequate for reliable quantitation required in pharmacokinetic and clinical studies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1430030     DOI: 10.1016/0021-9673(92)87133-s

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

1.  Determination of bupivacaine and metabolites in rat urine using capillary electrophoresis with mass spectrometric detection.

Authors:  Ryan M Krisko; Mark A Schieferecke; Todd D Williams; Craig E Lunte
Journal:  Electrophoresis       Date:  2003-07       Impact factor: 3.535

2.  Study on the interaction between verapamil hydrochloride and eosin Y by absorption, fluorescence and resonance Rayleigh scattering spectra and their analytical applications.

Authors:  Cuixia Li; Shaopu Liu; Zhongfang Liu; Xiaoli Hu
Journal:  J Fluoresc       Date:  2010-10-27       Impact factor: 2.217

3.  Electromigration behavior of polysaccharides in capillary electrophoresis under pulsed-field conditions.

Authors:  J Sudor; M Novotny
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

4.  Determination of bupivacaine and three of its metabolites in rat urine by capillary electrophoresis.

Authors:  M A Schieferecke; K J McLaughlin; A A Faibushevich; C E Lunte
Journal:  Electrophoresis       Date:  1998-11       Impact factor: 3.535

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.